Morphological variability and cell-wall deficiency in Mycobacterium tuberculosis 'heteroresistant' strains

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 8, 2005, Pages 907-914

  Michailova, L ^a   Kussovski, V ^a   Radoucheva, T ^a   Jordanova, M ^a   Berger, W ^b   Rinder, H ^c   Markova, N ^a   Markova, Nadya ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b UNIVERSITY OF MUNICH   (Germany)

^c State Dept for Health and Food Safety   (Germany)

Author keywords

Heteroresistance; L forms; M. tuberculosis

Indexed keywords

ISONIAZID; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; GENOTYPE; IN VIVO CULTURE; MORPHOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CELL WALL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE;

EID: 23744491471     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Domingue G J, Woody H B. Bacterial persistence and expression of disease. Clin Microbiol Rev 1997; 10: 320-344.
2. Judge M S, Mattman L H. Cell wall-deficient mycobacteria in tuberculosis, sarcoidosis, and leprosy. In: Domingue G J, ed. Cell wall-deficient bacteria: basic principles and clinical significance. Reading, MA: Addison-Wesley Publishing Co, 1982: p 257.
3. Mattman L H. Mycobacterium tuberculosis and atypicals. In: Mattman L H, ed. Cell wall deficient forms. Stealth Pathogens. 3rd ed. Boca Raton, FL: CRC Press, Inc, 2001: pp 189-200.
4. Takahashi S. L-phase growth of mycobacteria. 1. Cell-wall deficient form of mycobacteria. Kekkaku 1979; 54: 63-70.
5. Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci 2004; 9: 1136-1156.
6. Ratnam S, Chandrasekhar S. The pathogenicity of spheroplasts of Mycobacterium tuberculosis. Am Rev Respir Dis 1976; 114: 549-554.
7. Gillespie S H. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 2002; 46: 267-274.
8. Rinder H, Mieskes K T, Löscher T. Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2001; 5: 339-345.
9. Nikolaeva G M, Dorozkova I R. Morphology of changed tubercle bacilli forms. Probl Tuberk 1988; 4: 57-59.
10. Michailova L, Stoitsova S, Markova N, Kussovski V, Jourdanova M, Dimova I. Interaction of alveolar macrophages with Staphylococcus aureus and induction of microbial L-forms during infection in rats. Int J Med 2000; 290: 259-267.
11. Rinder H. Hetero-resistance: an under-recognised confounder in diagnosis and therapy? J Med Microbiol 2001; 50: 1018-1020.
12. Chandrasekhar S, Ratnam S. Studies on cell-wall deficient non-acid fast variants of Mycobacterium tuberculosis. Tubercle Lung Dis 1992; 73: 273-279.
13. Ulrichs T, Kaufmann S H E. Immunology and persistence. In: Kaufmann S H E, Hahn H, eds. Mycobacteria and TB. Basel, Switzerland: Karger, 2003: pp 112-127.
14. Amako K, Takade A, Umeda A, Matsuoka M, Yoshida S, Nakamura M. Degradation process of Mycobacterium leprae cells in infected tissue examined by the freeze-substitution method in electron microscopy. Microbiol Immunol 2003; 47: 387-394.
15. Domingue G J. Electron dense cytoplasmic particles and chronic infection: a bacterial pleomorphy hypothesis. Endocytobiosis Cell Res 1995; 11: 19-40.
16. Billington O J, McHugh T D, Gillespie S H. Physiological cost rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999; 43: 1866-1869.
17. Gillespie S H. Antibiotic resistance in the absence of selective pressure. Int J Antimicrob Agents 2001; 17: 171-176.
18. Wang H, Chen Z. Observation of properties of the L-form of M. tuberculosis induced by the antituberculosis drugs. Zhong-hua Jie He He Xi Za Zhi 2001; 24: 52-55.